Heart 2023 Conference

APRIL 20, 2022

JACC: Asia) Lexaria Bioscience has announced that a CBD product beats a placebo in simulating acute pulmonary hypertension.

Pulmonary 52

Pulmonary Hypertension AFIB COVID-19 52

Journal of the American Heart Association

NOVEMBER 28, 2023

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundLeft heart disease is the most common cause of pulmonary hypertension (PH) and is frequently accompanied by increases in pulmonary vascular resistance.

Pulmonary 40

Pulmonary Atrial Fibrillation Hypertension Heart Disease 40

Journal of the American Heart Association

NOVEMBER 28, 2023

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundPulmonary artery hypertension (PAH) is a fatal disease characterized by a complex pathogenesis. Transpulmonary exosomal miRs offer valuable insights into pulmonary circulation microenvironments.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Pulmonary Heart Disease 40

The American Journal of Cardiology

DECEMBER 31, 2023

Publication date: Available online 30 December 2023 Source: The American Journal of Cardiology Author(s): Tanmay Gokhale, Matthew E. Harinstein

Pulmonary 40

Pulmonary Hypertension 40

Dr. Smith's ECG Blog

JANUARY 20, 2024

Written by Pendell Meyers A man in his late 30s with history of hypertension, tobacco use, and obesity presented to the Emergency Department for acute chest pain which started approximately 3 hours prior to arrival, in the setting of a very stressful situation. Vitals were within normal limits except some hypertension. Which is true.

Chest Pain 120

Chest Pain STEMI Hypertension Blog 120

Dr. Smith's ECG Blog

SEPTEMBER 23, 2024

Written by Willy Frick with edits by Ken Grauer A woman in her 70s with a history of hypertension presented with acute onset shortness of breath. In patients with narrow QRS ( not this patient), this pattern is highly suggestive of acute pulmonary embolism. In PE, there is almost always some hypoxia without any pulmonary edema.

Cardiogenic Shock 127

Cardiogenic Shock Ultrasound Tachycardia Pulmonary 127

Frontiers in Cardiovascular Medicine

OCTOBER 13, 2024

A comparison between SSc patients with PAH (SSc-PAH) and those with PH and significant ILD (SSc-PH) was also carried out.Materials and methodsA retrospective single-center study in which all patients having SSc—complicated by PH—referring to the Scleroderma-Unit of the AOU Policlinico of Modena, from October 2013 to October 2023 were evaluated.

Pulmonary 52

Pulmonary Hypertension Risk Factors 52

Journal of Cardiovascular Pharmacology

DECEMBER 25, 2023

Shortness of breath and syncope are common symptoms of right ventricular failure caused by pulmonary arterial hypertension (PAH), which is the result of blockage and increased pressure in the pulmonary arteries. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Pulmonary 40

Pulmonary Hypertension Research Article 40

The American Journal of Cardiology

DECEMBER 13, 2023

Publication date: Available online 30 November 2023 Source: The American Journal of Cardiology Author(s): Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, Javier Jimenez, Shebin George, Jiana Baker, Juan Ruiz, Sandra Chaparro

Atrial Fibrillation 40

Atrial Fibrillation Pulmonary Hypertension Hospital 40

Journal of Cardiovascular Pharmacology

OCTOBER 30, 2023

Abstract: Pulmonary artery hypertension (PAH) is characterized by pulmonary arterial endothelial cells (PAECs) dysfunction and pulmonary artery smooth muscle cells (PASMCs) activation. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Pulmonary 40

Pulmonary Hypertension Article 40

DAIC

JUNE 19, 2024

While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

DAIC

JUNE 27, 2024

Anumana has received FDA Breakthrough Device Designation for four of its algorithms: low ejection fraction, pulmonary hypertension , cardiac amyloidosis, and hyperkalemia. FDA clearance in September 2023 and is currently under review in Europe.

Technology 105

Technology Heart Rhythm Innovation Heart Failure 105

Dr. Smith's ECG Blog

SEPTEMBER 17, 2023

large ASD, partial anomalous pulmonary venous return, significant tricuspid regurgitation, carcinoid valvular disease, etc,) 2) Conditions causing pressure overload of the RV. Any cause of pulmonary hypertension. At this point an old ECG on file was found for comparison.

Pulmonary 116

Pulmonary Tricuspid Chest Pain Cardiogenic Shock 116

Dr. Smith's ECG Blog

AUGUST 14, 2023

The bedside echo showed a large RV (Does this mean there is a pulmonary embolism as the etiology?) When you suspect pulmonary embolism due to large RV on POCUS, always look for right axis deviation and a large R-wave in V1 because the large RV may be entirely due to chronic RVH, not acute PE. Here is his triage ECG: What do you think?

Chest Pain 52

Chest Pain Pulmonary Sickle Cell Disease Atrial Flutter 52

BoardVitals - Cardiovascular

MAY 15, 2022

The Cardiology MOC exam will be offered on April 3, 2023, and October 11, 2023. Heart Failure and Cardiomyopathy 19% Valvular Disease 15% Pericardial Disease 3% Congenital Heart Disease 3% Vascular Diseases 5% Systemic Hypertension and Hypotension 8.5% What are some things you need to know before you sit for the exam?

Certification 52

Certification Congenital Heart Disease Coronary Artery Disease Cardiovascular Disease 52

Stroke Journal

FEBRUARY 1, 2024

There were no differences with rates of hypertension, hyperlipidemia, diabetes, smoking, heart failure, and pulmonary hypertension among MPN Veterans with stroke with and without AO exposure.In ICD-9 and -10 codes identified Veterans with stroke and MPN. AO exposure was verified on the Veterans’ service duration and location.

Hemorrhage 40

Hemorrhage Strokes Stroke Hypertension 40

Dr. Smith's ECG Blog

FEBRUARY 12, 2023

This suggests that there is pulmonary hypertension and thus possibly RVH. The estimated pulmonary artery systolic pressure is 31 mmHg + RA pressure. Troponin peaked at 2914 ng/L = Comment by K EN G RAUER, MD ( 2/12 /2023 ): = Among the most challenging of ECG diagnoses to make is RVH ( R ight V entricular H ypertrophy ).

Pulmonary 40

Pulmonary Chest Pain Hypertension Tricuspid 40

Dr. Smith's ECG Blog

APRIL 9, 2023

Submitted by Ali Khan MD and James Mantas MD, MS, written by Pendell Meyers A man in his 50s with history of diabetes, hypertension, and tobacco use presented to the ED with 24 hours of worsening left sided chest pain radiating to the back, characterized as squeezing and pinching, associated with shortness of breath.

Chest Pain 52

Chest Pain Ischemia Stenosis Pulmonary 52

Dr. Smith's ECG Blog

JANUARY 27, 2024

See these posts: Chest Pain, ST Elevation, and an Elevated Troponin: Should we Activate the Cath Lab? Patterns of occlusion and reperfusion can be learned and taught, including to AI 4.

Chest Pain 117

Chest Pain STEMI Aneurysm Stents 117

Dr. Smith's ECG Blog

JULY 7, 2023

An old formal echo was found from 6 mo ago: Dilated right ventricle with septal flattening and estimated right ventricular systolic pressure of 70 mmHg (significant pulmonary hypertension). She ruled out for acute MI by troponins. See further discussion of R/S ratio greater than 1 in lead V1 by Ken below.

Chest Pain 52

Chest Pain AFIB Blog Atrial Fibrillation 52

Dr. Smith's ECG Blog

JULY 27, 2023

The estimated pulmonary artery systolic pressure is 29 mmHg + RA pressure. While hypertension and sinus tachycardia are the most common manifestations — a variety of other tachyarrhythmias ( including VT leading to cardiac arrest ) and acute MI may be seen. Potential cardiovascular effects of acute amphetamine use are multiple.

Tachycardia 52

Tachycardia Ischemia Cardiac Arrest Echocardiogram 52

Circulation

NOVEMBER 11, 2024

Background:Research into pulmonary hypertension (PH) reveals significant sex-based disparities in long-term survival rates. Circulation, Volume 150, Issue Suppl_1 , Page A4138397-A4138397, November 12, 2024. Through diagnostic codes, medical records, and imaging studies, 3,296 PH cases and 497,580 cases without PH were identified.

Pulmonary 40

Pulmonary Hypertension BMI Outcomes 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Dr. Smith's ECG Blog

MARCH 3, 2025

A 69 year old woman with a history of hypertension presented to the emergency department by EMS for evaluation of chest pain and shortness of breath. I suspect pulmonary edema, but we are not given information on presence of B-lines on bedside ultrasound, or CXR findings. Acute coronary occlusion and acute pulmonary edema can coexist.

Tachycardia 73

Tachycardia Pulmonary Chest Pain Stenosis 73

CardiacWire

NOVEMBER 27, 2024

Stunning topline results from Merck Winrevair’s Phase 3 ZENITH trial found that the drug significantly reduced morbidity and mortality risks in patients with pulmonary arterial hypertension, paving the way for stronger commercialization and further functional trials.

Blood Pressure 52

Blood Pressure Pulmonary Transplant Hypertension 52